Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility, Efficacy and Safety of IBS ® for Implantaiton in the PDA in Duct-dependent Cyanotic CHD

NCT04291222 is registered in ClinicalTrials.gov with Lifetech Scientific (Shenzhen) Co., Ltd. as lead sponsor.

NCT NCT04291222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04291222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility, Efficacy and Safety of IBS ® for Implantaiton in the PDA in Duct-dependent Cyanotic CHD
Lead sponsor
Lifetech Scientific (Shenzhen) Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
December 11, 2018
Completion date
August 31, 2021
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

duct-dependent cyanotic congenital heart disease, patent ductus arteriosus